BEIJING--(BUSINESS WIRE)--Oct 26, 2023--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase III registrational trial of the Company鈥檚 BTK ...
SAN DIEGO--(BUSINESS WIRE)--Oct 26, 2023--Fore Genomics, Inc. announced the launch of its revolutionary FORESITE 360鈩� service using whole genome sequencing (WGS) today, which gives you a complete map (100%) of your baby鈥檚 DNA with a simple at-home collection kit. FORESITE 360鈩� is a 100% ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 26, 2023--Foundation Medicine, Inc., today announced its participation in the National Cancer Institute鈥檚 (NCI) Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH) initiative to test new therapy combinations in ...
NYON, Switzerland--(BUSINESS WIRE)--Oct 26, 2023--Edwards Lifesciences today announced it received CE Mark for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position. The MITRIS RESILIA valve is made with innovative bovine pericardial tissue ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Oct 25, 2023--<a ...
LOWELL, Mass.--(BUSINESS WIRE)--Oct 25, 2023--RevBio, Inc., announced that it has received a grant from the National Institutes of Health through its Helping to End Addiction Long-term Initiative, or <a ...
